Comparison between Curis Lifesciences IPO and Srinibas Pradhan Constructions IPO.
Curis Lifesciences IPO is a SME Bookbuilding IPO proposed to list at NSE SME while Srinibas Pradhan Constructions IPO is a SME Bookbuilding proposed to list at NSE SME.
| Curis Lifesciences IPO | Srinibas Pradhan Constructions IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | NSE SME | NSE SME |
| Lead Managers | Finaax Capital Advisors Private Limited | Novus Capital Advisors Private Limited |
| Registrar | MUFG Intime India Pvt.Ltd. | Maashitla Securities Pvt.Ltd. |
| Market Maker | RS Wealth Management Private Limited | Rikhav Securities Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | Anchor Investor | |
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Curis Lifesciences IPO is up to ₹26.14 Cr whereas the issue size of the Srinibas Pradhan Constructions IPO is up to ₹19.30 Cr. The final issue price of Curis Lifesciences IPO is ₹128.00 per share and of Srinibas Pradhan Constructions IPO is ₹98.00 per share.
| Curis Lifesciences IPO | Srinibas Pradhan Constructions IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹120.00 per share | ₹91.00 per share |
| Issue Price (Upper) | ₹128.00 per share | ₹98.00 per share |
| Issue Price (Final) | ₹128.00 per share | ₹98.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 1000 shares | 1200 shares |
| Fresh Issue Size | 20,42,000 shares | 16,09,200 shares |
| Fresh Issue Size (Amount) | up to ₹26.14 Cr | up to ₹15.77 Cr |
| OFS Issue Size | 0 shares | 3,60,000 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹3.53 Cr |
| Issue Size Total | 20,42,000 shares | 19,69,200 shares |
| Issue Size Total (Amount) | up to ₹26.14 Cr | up to ₹19.30 Cr |
Curis Lifesciences IPO opens on Nov 07, 2025, while Srinibas Pradhan Constructions IPO opens on Mar 06, 2026. The closing date of Curis Lifesciences IPO and Srinibas Pradhan Constructions IPO is Nov 11, 2025, and Mar 10, 2026, respectively.
| Curis Lifesciences IPO | Srinibas Pradhan Constructions IPO | |
|---|---|---|
| Anchor Bid Date | Nov 06, 2025 | |
| Issue Open | Nov 07, 2025 | Mar 06, 2026 |
| Issue Close | Nov 11, 2025 | Mar 10, 2026 |
| Basis Of Allotment (Tentative) | Nov 12, 2025 | Mar 11, 2026 |
| Initiation of Refunds (Tentative) | Nov 13, 2025 | Mar 12, 2026 |
| Credit of Share (Tentative) | Nov 13, 2025 | Mar 12, 2026 |
| Listing date (Tentative) | Nov 14, 2025 | Mar 13, 2026 |
| Anchor Lockin End date 1 | Dec 11, 2025 | |
| Anchor Lockin End date 2 | Feb 09, 2026 |
Curis Lifesciences IPO P/E ratio is 12.44, as compared to Srinibas Pradhan Constructions IPO P/E ratio of 9.15.
| Curis Lifesciences IPO | Srinibas Pradhan Constructions IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)Curis Lifesciences Ltd.'s revenue increased by 38% and profit after tax (PAT) rose by 25% between the financial year ending with March 31, 2025 and March 31, 2024.
| Company Financials (Restated Consolidated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 92.68 | 85.27 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 68.03 | 62.1 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 12.44 | 9.15 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹103.48 Cr. | ₹77.04 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 55.25 | 55.76 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 27.83 | 71.01 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.96 | 1.08 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹10.29 | ₹10.71 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 37.62 | 55.76 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Curis Lifesciences IPO Retail Individual Investors (RII) are offered 7,16,000 shares while in Srinibas Pradhan Constructions IPO retail investors are offered 7,16,000 shares. Qualified Institutional Buyers (QIB) are offered 4,08,000 shares in Curis Lifesciences IPO and 19,200 shares in Srinibas Pradhan Constructions IPO.
| Curis Lifesciences IPO | Srinibas Pradhan Constructions IPO | |
|---|---|---|
| Anchor Investor Reservation | 6,09,000 shares | 0 shares |
| Market Maker Reservation | 1,08,000 shares | 1,04,400 shares |
| QIB | 4,08,000 shares | 19,200 shares |
| NII | 3,09,000 shares | 9,75,600 shares |
| RII | 7,16,000 shares | 9,74,400 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 20,42,000 shares | 19,69,200 shares |
Curis Lifesciences IPO subscribed 74.39x in total, whereas Srinibas Pradhan Constructions IPO subscribed 1.13x.
| Curis Lifesciences IPO | Srinibas Pradhan Constructions IPO | |
|---|---|---|
| QIB (times) | 96.17x | 1.13x |
| NII (times) | 115.46x | 1.57x |
| Big NII (times) | 142.74x | 2.22x |
| Small NII (times) | 60.38x | 0.27x |
| RII (times) | 44.28x | 0.69x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 74.39x | 1.13x |
